BioCardia, Inc. (BCDA) Social Stream
BIOCARDIA INC (BCDA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIOCARDIA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-01 | 3 | $15 | $7 | $11 | $0.662 | 1561.63% |
| 2021-12-20 | 3 | $15 | $7 | $10.333 | $0.662 | 1460.88% |
| 2022-02-03 | 4 | $15 | $7 | $10.333 | $0.662 | 1460.88% |
| 2022-04-12 | 4 | $15 | $4 | $8.75 | $0.662 | 1221.75% |
| 2022-05-20 | 4 | $15 | $3 | $8.5 | $0.662 | 1183.99% |
| 2022-08-31 | 4 | $15 | $3 | $7.75 | $0.662 | 1070.69% |
| 2022-10-05 | 2 | $9 | $3 | $5.333 | $0.662 | 705.59% |
| 2022-11-10 | 2 | $9 | $3 | $5.333 | $0.662 | 705.59% |
| 2023-05-11 | 2 | $9 | $4 | $6.333 | $0.662 | 856.65% |
| 2023-08-10 | 2 | $9 | $6 | $7.5 | $0.662 | 1032.93% |
| 2023-11-09 | 2 | $6 | $4 | $5 | $0.662 | 655.29% |
The Trend in the Analyst Price Target
Over the past 31 months, BCDA's average price target has gone down $6.63.
BCDA reports an average of 614.13% for its upside potential over the past 32 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 2 | 9 | 4 | 6.333 | 1.940 | 226.44% |
| 2023-05-11 | 2 | 9 | 4 | 6.333 | 2.000 | 216.65% |
| 2023-07-24 | 2 | 9 | 6 | 7.500 | 1.095 | 584.93% |
| 2023-09-06 | 2 | 6 | 4 | 5.000 | 0.507 | 886.19% |
| 2023-11-09 | 2 | 4 | 4 | 4.000 | 0.410 | 875.61% |
BCDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
BCDA's average broker recommendation rating worsened by 1 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BCDA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, BIOCARDIA INC's upside potential (average analyst target price relative to current price) is greater than 1262.24% of them.
- In the context of all US stocks, BIOCARDIA INC's number of analysts covering the stock is greater than 88.01% of them.
- BIOCARDIA INC's average analyst price target is greater than 103.12% of all US stocks.
- In the context of stocks in the small market cap category, BIOCARDIA INC's variance in analysts' estimates is lower than -810.98% of them.
Stocks similar to BIOCARDIA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LIFE, DBVT, and EIGR.
View All Top Stocks by Price Target
Is BCDA a Buy, Hold or Sell? See the POWR Ratings now!